1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
